Increasing the Number of Clinical Trials Available to Adolescents Diagnosed With Cancer-Reference-Cited by-同舟云学术

Increasing the Number of Clinical Trials Available to Adolescents Diagnosed With Cancer

Published:2014-06-01 Issue:Supplement_3 Volume:133 Page:S114-S118
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Gupta Abha A.¹,Indelicato Daniel J.²

Affiliation:

1. Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; and

2. Department of Radiation Oncology, University of Florida, Jacksonville, Florida

Abstract

Improving access to clinical trials for adolescents with cancer remains an important issue for pediatric health care providers. In this brief report, we highlight barriers to increasing the number of clinical trials as a mechanism for addressing this problem. The challenges discussed include: (1) engaging stakeholders to increase funding; (2) increasing cooperation between clinical trial cooperative groups; and (3) permitting delivery of novel drugs to postpubertal adolescents, in the absence of formal pediatric Phase I evaluation.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology, and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/133/Supplement_3/S114/895635/peds_2014-0122g.pdf

Reference18 articles.

1. National cancer clinical trials: children have equal access; adolescents do not.;Bleyer;J Adolesc Health,1997

2. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?;Parsons;J Clin Oncol,2011

3. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival: 1975-2000;Bleyer,2006

4. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials.;Bleyer;Med Pediatr Oncol,2002

5. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee.;Gupta;Cancer,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and limitations of clinical trials in the adolescent and young adult CNS cancer population: A systematic review;Neuro-Oncology Advances;2023-12-10

2. Systems-Level Change to Alleviate Barriers to Cancer Clinical Trial Access for Adolescents and Young Adults in Australia;Journal of Adolescent and Young Adult Oncology;2021-07-22

3. Strategies for improving access to clinical trials by teenagers and young adults with cancer: A qualitative study of health professionals’ views;European Journal of Cancer Care;2021-01-20

4. Evaluation of Adolescents’ and Young Adults’ Attitudes Toward Participation in Cancer Clinical Trials;JCO Oncology Practice;2020-03

5. NCDs and the WHO Essential Medicines Lists: children need universal health coverage too;The Lancet Child & Adolescent Health;2019-11